Myelodysplastic Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Unified platforM for a Better integRal Evaluation of MyeLodyspLastic Syndromes in SpAin-Strategy for Unraveling Personalized genoMic Medicine in Public heAlth System (UMBRELLA-SUMMA)
Conditions: Myelodysplastic Syndromes Sponsors: Instituto de Investigaci ón Biomédica de Salamanca; Carlos III Health Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials

A Study of GLB-001 in Patients With Myeloid Malignancies
Conditions: Polycythemia Vera; Essential Thrombocythemia; Myelofibrosis; Myelodysplastic Syndromes; Acute Myeloid Leukemia; Myeloid Malignancy Interventions: Drug: GLB-001 Sponsors: Hangzhou GluBio Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials

A Study to Investigate APL-4098 Alone and/or in Combination With Azacitidine in R/R AML and High-Risk MDS
Conditions: Acute Myeloid Leukemia Refractory; Myelodysplastic Syndrome Acute Myeloid Leukemia; Myelodysplastic Syndrome With Excess Blasts; Acute Myeloid Leukemia, in Relapse Interventions: Drug: APL-4098; Drug: Azacitidine and APL-4098 Sponsors: Apollo Therapeutics Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials

Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome/Acute Myeloid Leukemia Interventions: Drug: Azacitidine; Procedure: Biospecimen Collection; Procedure: Bone Marrow Biopsy; Procedure: Echocardiography; Drug: Iadademstat; Procedure: Multigated Acquisition Scan; Other: Questionnaire Administration; Drug: Venetoclax Sponsors: OHSU Knight Cancer Institute; Oregon Health and Science University; Oryzon Genomics S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial
Conditions: Acute Lymphoblastic Leukaemia; Acute Leukemia of Ambiguous Lineage; Chronic Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome; Acute Myeloid Leukemia Interventions: Drug: EBX-102; Drug: Placebo Sponsors: Imperial College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials

Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndromes Interventions: Drug: Venetoclax; Drug: Decitabine; Drug: Fludarabine; Drug: Busulfan; Radiation: Total Body Irradiation Sponsors: Northside Hospital, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials

A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML
Conditions: Recurrent Adult Acute Myeloid Leukemia; Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia Interventions: Drug: CMGV Sponsors: Ruijin Hospital; Huadong Hospital; Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine; Huashan Hospital; Army Medical Center of PLA; Sun Yat-sen University; RenJi Hospital; Shanghai Jiading District Central Hospital; The Second Affiliated Hospital of Dalian Medical University; First Hospital of China Medical University; Dalian Municipal Central Hospital; Shanghai Zhongshan Hospital; Shanghai Pudong Hospital; Shanghai Public Health Clinical Center; Xuhui Cent...
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
Conditions: GVHD,Acute; Acute Leukemia; Myelodysplastic Syndromes; Myeloproliferative Disorders Interventions: Drug: ATG Combined with Tacrolimus and Mini Methotrexate Sponsors: University of Alabama at Birmingham Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials

Keros Therapeutics Announces U.S. FDA Fast Track Designation for KER-050 in Lower-Risk Myelodysplastic Syndromes
LEXINGTON, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 14, 2024 Category: Pharmaceuticals Source Type: clinical trials

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Conditions: Myelodysplastic Syndromes Interventions: Drug: pacritinib Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome
Conditions: Myelodysplastic Syndromes Anemia Interventions: Drug: AND017 Sponsors: Kind Pharmaceuticals LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

PTCy and ATG for MSD and MUD Transplants
Conditions: Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndromes; Hodgkin Lymphoma; Non-hodgkin Lymphoma Interventions: Drug: ATG 5.0; Drug: Cyclophosphamide injection; Drug: ATG 2.5 ±1.5 Sponsors: Instituto Nacional de Cancer, Brazil Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials

Study of REM-422 in Patients With AML or Higher Risk MDS
Conditions: Myelodysplastic Syndromes; Higher Risk Myelodysplastic Syndromes; Acute Myeloid Leukemia; Acute Myeloid Leukemia Refractory Interventions: Drug: REM-422 Sponsors: Remix Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials

Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan
Conditions: Lower-risk Myelodysplastic Syndromes Interventions: Procedure: Red blood cell transfusion; Procedure: Red blood cell transfusion Sponsors: Bristol-Myers Squibb Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials

A Study of Single and Multiple Dose Administration of LP-001 in Healthy Subjects
Conditions: Myelodysplastic Syndrome (MDS) Interventions: Biological: LP-001 Dose 1 (Single); Biological: LP-001 Dose 2 (Single); Biological: LP-001 Dose 3 (Single); Biological: LP-001 Dose 4 (Single); Biological: LP-001 Dose 5 (Single); Biological: LP-001 Dose 6 (Single); Biological: Placebo (Single); Biological: LP-001 Dose 7 (Multiple); Biological: LP-001 Dose 8 (Multiple); Biological: Placebo (Multiple) Sponsors: Longbio Pharma Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials